Tafluprost ethyl ester (AFP-175) is a specialty chemical and synthetic analog of tafluprost, a prostaglandin F2α derivative used primarily in pharmaceutical research and development for ophthalmology. It serves as an intermediate or prodrug form that can be hydrolyzed to the active acid, aiding in the treatment of glaucoma and ocular hypertension by reducing intraocular pressure through enhanced outflow of aqueous humor. This compound is suitable for formulation into eye drops and is effective in long-term management of elevated eye pressure to prevent optic nerve damage and vision loss. With 98% purity, it is ideal for research applications requiring high specificity and low impurities.